콘텐츠로 건너뛰기
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Menu
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Get In Touch

Press Release

HOME > NEWS > Press Release​

PharmCADD CEO gave special lecture in the national pharma-bio forum

READ MORE

PharmCADD embarks on joint development project for Covid-19 vaccine

READ MORE

PharmCADD launches AI-based drug design platform “Pharmulator” Version 1.0 at CES 2020

READ MORE

PharmCADD, SK Bio Pharm, other Korean firms join forces for drug development, using AI technologies

READ MORE

PharmCADD, University of Groningen sign MOU for in-silico drug development collaboration

READ MORE

PharmCADD, Kosin Univ. Gospel Hospital sign MOU for new drug development., patient data sharing

READ MORE

PharmCADD attracts another 1 billion won in seed funding from DTN Investment

READ MORE

PharmCADD succeeds in attracting 1.5 billion won in initial seed funding from KTB

READ MORE
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681
Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.